This information may allow clinicians to improve candidates’ selection for DBS and refine prognostic accuracy (e.g., GBA1 genetic status influence on speech) and that, if necessary, early speech interventions should be used after surgery in PD patients treated with STN-DBS at a higher risk of speech deterioration. Here, GBA1 is linked to Parkinson disease.